Top Markets
Coin of the day
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
株式のランク #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
株価
$4.62
最終同期: 2023-03-23
時価総額
$171.76M
変化(1日)
-37.16%
変化(1年)
0.00%
KR
取引 Cellivery Therapeutics, Inc. (268600)

カテゴリー

Cellivery Therapeutics, Inc.(268600)の配当利回りの履歴
Cellivery Therapeutics, Inc.(銘柄コード: 268600)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Cellivery Therapeutics, Inc.(268600)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)